Circumvention of acquired resistance to doxorubicin in K562 human leukemia cells by oxatomide.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002462:Cell Membrane / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D004317:Doxorubicin / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D019450:Genes, MDR / Q000235:genetics; D006801:Humans; D020014:K562 Cells; D007938:Leukemia / Q000188:drug therapy*; D010777:Photochemistry; D010879:Piperazines / Q000494:pharmacology*